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Abstract
Introduction: Fine needle aspiration biopsy (FNAB) is the main examination in diagnostics of thyroid nodules. Yet, it does not allow the 
differentiation of follicular lesions (FL). A new classification of thyroid biopsy results (newC) might improve pre-operative diagnostics 
mainly due to the introduction of a new subcategory of ‘follicular lesion of undetermined significance’, as well as the clarification of 
definitions of other categories. 
The aim of this study was to analyse the impact of the newC on the distribution of the cytological results among main diagnostic categories 
and on the values of the parameters describing the effectiveness of FNAB in detecting malignancy.
Material and methods: 34,371 FNABs outcomes and 3,557 results of surgical follow up were analysed. The frequencies of five main di-
agnostic categories in two periods: before (years: 2000–2009, 24,271 FNAB) and after the newC had been introduced (years: 2010–2012, 
10,100 FNAB) were compared, as well as parameters describing the biopsy effectiveness, with a special focus on FL. 
Results: In the second analysed period, the frequency of the ‘suspicious for malignancy’ results was three times lower, while diagnoses 
of ‘malignant neoplasm’ were 33% more frequent and the results corresponding to FL decreased by 10%. In respect to FL, specificity of 
FNAB increased (22.6% vs. 57.4%), but sensitivity decreased (78.8% vs. 50.0%). In respect to other diagnostic categories considered jointly, 
the sensitivity of FNAB (61.2% vs. 85.7%) and PPV (57.4% vs. 77.8%) increased, and the specificity was similar (95-97%) for both periods. 
NPV exceeded 95% irrespective of applied classification.
Conclusions: Separation of FL with low risk of malignancy affects the values of the parameters describing the effectiveness of FNAB. The 
improved diagnostic effectiveness of FNAB is also a consequence of epidemiological changes and better selection of thyroid lesions for 
biopsy. (Endokrynol Pol 2014; 65 (6): 431–437)
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Streszczenie
Wstęp: Biopsja aspiracyjna cienkoigłowa (BAC) jest podstawowym badaniem stosowanym w diagnostyce guzków tarczycy, jednak jej 
wyniki są często niejednoznaczne, szczególnie dotyczy to zmian pęcherzykowych. Nowa klasyfikacja wyników BAC tarczycy (newC), 
w której wyodrębniono podkategorię „zmiana pęcherzykowa bliżej nieokreślona” oraz uściślono definicje pozostałych kategorii, miała 
poprawić skuteczność tego badania. Jednak dotąd nie ma wystarczających analiz następstw jej wprowadzenia.
Celem pracy była analiza wpływu wprowadzenia nowej klasyfikacji wyników biopsji tarczycy na częstość formułowania głównych ka-
tegorii diagnostycznych oraz wartości parametrów opisujących skuteczność BAC w ujawnianiu nowotworów złośliwych.
Materiał i metody: Analizowano wyniki 34371 BAC. Porównano częstość formułowania pięciu głównych kategorii diagnostycznych w 
dwóch okresach: przed (lata 2000–2009, 24271 BAC) oraz po wprowadzeniu newC (lata 2010–2012, 10100 BAC). Przeprowadzono weryfi-
kację histopatologiczną wyników biopsji 3557 pacjentów. Porównano parametry opisujące skuteczność BAC w odniesieniu do ujawniania 
nowotworów złośliwych dla dwóch powyższych okresów, ze szczególnym uwzględnieniem zmian pęcherzykowych.
Wyniki: W drugim z okresów doszło do 3-krotnego zmniejszenia częstości formułowania wyników „podejrzenie nowotworu złośliwego”, 
33% wzrostu częstości rozpoznań „nowotwór złośliwy” oraz 10% spadku częstości wyników odpowiadających FL. W odniesieniu do zmian 
pęcherzykowych wzrosła swoistość badania (22.6% vs. 57.4%), zaś obniżyła się czułość (78.8% vs. 50.0%). W odniesieniu do pozostałych 
kategorii diagnostycznych łącznie — czułość (61.2% vs. 85.7%) i PPV (57,4% vs. 77,8%) wzrosły, swoistość była podobna (95-97%) dla obu 
okresów. NPV niezależnie od stosowanej klasyfikacji przekraczała 95%.
Wnioski: Wydzielenie podgrupy zmian pęcherzykowych o niskim ryzyku złośliwości istotnie zmienia wartości parametrów określa-
jących skuteczność BAC. Poprawa efektywności BAC wynika także ze zmian epidemiologicznych i trafniejszej selekcji ognisk do BAC. 
(Endokrynol Pol 2014; 65 (6): 431–437)
Słowa kluczowe: tarczyca; biopsja aspiracyjna cienkoigłowa; rak tarczycy; zmiana pęcherzykowa bliżej nieokreślona
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margins, intranodular vascular pattern). Smears were 
fixed in 95% ethanol solution and stained with hema-
toxylin and eosin. A detailed description of the FNAB 
procedure was presented in our earlier work [5]. 
The frequency of formulating five main diagnostic 
categories of FNAB results (non-diagnostic — ND; be-
nign lesions — BL; follicular lesions — FL; suspicious 
for malignancy — SM; and malignant neoplasm — MN) 
was compared for two periods: before (2000–2009) and 
after (2010–2012) introducing the newC. This classifica-
tion divides diagnoses of FL into FLUS and ‘suspicious 
for follicular neoplasm’ (SFN) subcategories [3, 4]. A di-
agnosis of FLUS was made when the specimen showed 
features of both benign thyroid nodule and follicular 
neoplasm or showed low cellularity with the presence 
of architectural or nuclear atypia. Before 2010, in some 
cases, the cytopathologist also tried to determine more 
precisely the benign character of the follicular lesion by 
formulating the result as ‘follicular neoplasm probably 
benign’ (FN-pB). The categories SFN (which has been 
used since 2010) and ‘follicular neoplasm’ (FN – which 
had been used up to 2010) were defined according to 
similar criteria. 
In the case of examining more than one nodule by 
the same FNAB, cytologic outcomes were always clas-
sified to the category corresponding to the highest risk 
of malignancy. All performed FNABs were included in 
the analysis — also multiple control ones carried out in 
patients with benign lesions, ordered by some physi-
cians every 1–2 years. The percentage of repeat FNABs 
was similar in subsequent years. In cases of multinodu-
lar goitre, other lesions were usually biopsied during 
repeat examination. 
At the next stage, the surgical follow-up was 
analysed. In those analyses, all the cases of malignant 
neoplasms were considered, including very small le-
sions and neoplasms revealed in a lesion other than the 
biopsied one. The post-operative outcomes were clas-
sified into two groups: malignant neoplasms and oth-
ers. The diagnostic value of FNAB (with the exclusion 
of non-diagnostic outcomes) was assessed in terms of 
sensitivity, specificity, positive and negative predictive 
values (PPV, NPV). We also compared the parameters 
describing the effectiveness of FNAB in the two men-
tioned periods. MN and SM cytology outcomes were 
treated as positive for malignancy and BL was treated 
as negative. As far as FL was concerned, they were 
classified into two subgroups. The diagnoses of FLUS 
and FNpB were considered negative with regard to 
malignancy, and consequently as an indication to con-
servative treatment. The categories SFN and FN were 
classified as positive for malignancy, which meant an 
indication for surgery. We also analysed the sensitivity, 
specificity, PPV, and NPV exclusively for FL as well as 
Introduction
Morphological lesions of the thyroid are among the 
most common disorders of the endocrine system. In 
postendemic areas such as Poland, due to long-term 
insufficient iodine prophylaxis, lesions are common 
among elderly and middle-aged people [1]. In general 
these lesions are non-neoplastic, however, differen-
tiation between them and malignant neoplasms is 
required. The main examination applied for this pur-
pose is fine needle aspiration biopsy (FNAB). But this 
has some limitations, the main one being that it is not 
possible to identify each type of follicular lesion [2]. 
A new classification of thyroid biopsy results has been 
introduced to reduce this limitation by describing 
a new subcategory: ‘follicular lesion of undetermined 
significance’ (FLUS). This category is supposed to be 
an indication for control FNAB in order to clarify the 
diagnosis [3, 4]. Our previous analyses demonstrated 
that FLUS mainly allows the extraction from the group 
of follicular lesions ones that are associated with a lower 
risk of cancer [5]. However, the definition of FLUS is 
wider. It includes not only the borderline microscopic 
image of benign lesions and follicular neoplasms, but 
also the borderline results suspicious for malignancy 
(when characteristic features of benign and malignant 
lesions coexist in smears and the cellularity of aspirate 
is scant) [3]. 
As a result, the introduction of this subcategory con-
cerning follicular lesions could have a significant impact 
on the distribution of cytological outcomes among other 
diagnostic categories as well (benign lesions and suspi-
cious for malignancy or even non-diagnostic results). 
Thus, the aims of our study were: the analysis of the 
impact of the new classification of the thyroid biopsy 
results on the frequency of formulating main diagnostic 
categories and the comparison of FNAB’s effectiveness 
in detecting malignancy using both the new (newC) 
and the old (oldC) cytology classification systems, with 
special focus on ‘follicular lesions’. 
Material and methods
The analysis included the outcomes of FNABs per-
formed at the Department of Ultrasonography and 
Thyroid Biopsy, University Hospital in Lodz between 
2000 and 2012. The examinations were carried out in 
patients referred by endocrinologists from outpatient 
clinics. All the biopsies were US-guided. FNABs were 
performed on nodules with a diameter of at least 5 mm, 
which were palpable or had at least one malignancy risk 
factor (intranodular microcalcifications, ratio of ante-
rior–posterior dimension to the transverse dimension 
≥ 1, hypoechogenicity, presence of irregular, blurred 
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for other cytological diagnostic categories jointly after 
exclusion of FL. 
The comparison of frequency distributions was 
performed with Chi-square test. Continuous variables 
(the age of patients) were analysed with ANOVA and 
Newman-Keuls test. The comparison of diagnostic 
value of FNABs in detecting malignancy with the use 
of oldC and newC was performed by evaluation of the 
areas under ROC curves. The value of p < 0.05 was 
assumed as the level of significance. 
The study design was approved by the Bioethical 
Committee of the Medical University of Lodz.
Results
In the whole examined period (2000–2012), 34,371 
FNABs were performed. The mean age of all patients 
was 57.4 ± 15.5 years (mean ± SD, min: 10, max: 91). 
Table I shows the distribution of all the diagnostic results 
to each of the main diagnostic categories in the two 
analysed periods. It was found that after the introduc-
tion of the newC of FNAB results, MN were formulated 
more often (0.6% vs. 0.8%, p < 0.005) and at the same 
time FL (7.3% vs. 6.6%, p < 0.05) and SM (1.2% vs. 0.4%, 
p < 0.0001) were formulated less often. 
When analysing groups of SM and MN more closely, 
it was found that in the period 2000-2005, the percent-
age of SM results was three times higher than that of 
the MN category in every year, while in the next four 
years the results of both categories had a similar fre-
quency. In the last three years, the initial relationship 
was reversed and MN outcomes were formulated two 
times more often than a diagnosis of SM. In 2000–2009, 
the MN category accounted for 31.9% of all the results 
classified as SM or MN, while 2010–2012 — it was 66.7%, 
p < 0.0001 (Fig. 1). In 2000–2005, 32.4% of MN diagnoses 
were related to lesions < 1 cm in diameter, and in the 
next years that number amounted to 40.2%. In the last 
three examined years — 2010–2012 — as much as 45.6% 
of MN diagnoses were related to such small lesions 
(p = 0.07 vs. 2000–2005).
Among MN, papillary thyroid cancer prevailed — 
(59.3% — 131 patients); in two cases (1.0%) follicular 
cancer was revealed of oxyphillic type, yet in one person 
it was a recurrent cancer; in 16 patients (7.2%) medul-
lary cancer was diagnosed; in 12 (5.4%) — anaplastic 
cancer was found and in five (2.3%) malignant lympho-
ma. In 11 patients (5.0%), a metastasis to the thyroid was 
found — (from: breast cancer, oat-cell bronchial cancer, 
renal clear-cell cancer, and in some cases the primary 
localisation was impossible to determine). In 44 (19.8%) 
smears, a malignant tumour of unknown histogenesis 
was found. In 35.3% of SM results (118 cases) there were 
single features of papillary thyroid cancer present in the 
smear, in others a considerable anisocytosis was found 
that was not justified by clinical data. 
Table II summarises the results of thyroid FNABs 
with the results of histopathology in the two analysed 
periods. In the group of operated patients, it was found 
that the percentage of individuals with BL FNAB cat-
egory decreased from 79.6% in the first period to 57.1% 
in the second one (p < 0.0001), while the percentage of 
persons with FL category and MN category increased 
— from 11.7% to 26.2% (p < 0.0001) and from 2.9% to 
10.2% (p < 0.0001), respectively. Consequently, in the 
second period, thyroid cancers were more frequently 
revealed in postoperative histopathological examina-
tion (14.4% vs. 6.9%, p < 0.0001) than in the first one. 
Moreover, in patients with thyroid cancer the frequency 
Table I. The distribution of main diagnostic categories in the 
years 2000–2009 and 2010–2012 — i.e. before and after the 
introduction of the new classification of thyroid biopsy results 
Tabela I. Rozkład głównych kategorii diagnostycznych FNAB 
w latach 2000–2009 i 2010–2012 — przed i po wprowadzeniu 
nowej klasyfikacji wyników FNAB
FNAB results 
(No/%)
  2000–2009 2010–2012 p
ND   1,941/8.0 847/8.4 NS
BL   20,136/82.9% 8,461/83.8% NS
FL  1,765/7.3% 666/6.6%  p < 0.05
SM   292/1.2% 42/0.4%     p < 0.0001
MN   137/0.6% 84/0.8%  p < 0.005
Total  24,271/100% 10,100/100%
ND — non-diagnostic results; BL — benign lesions; FL — follicular lesions; SM 
— suspicion for malignancy; MN — malignant neoplasms
Figure 1. Mutual percentage rate of categories: ‘suspicion for 
malignancy’ and ‘malignant neoplasm’. SM — suspicion for 
malignancy; MN — malignant neoplasm
Rycina. 1. Wzajemny udział procentowy kategorii „podejrzenie 
nowotworu złośliwego” i „nowotwór złośliwy”. SM — podejrzenie 
złośliwości, MN — nowotwór złośliwy
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of MN FNAB results significantly increased from 42.5% 
to 66.1% (p < 0.005) and BL results became less common 
(from 32.4% to 12.5%; p < 0.005).
Table III presents the parameters describing FNAB’s 
effectiveness with regard to revealing cancer in the two 
mentioned periods. In the second period, the incidence 
of true positive (TP) outcomes significantly increased 
from 4.5% to 12.1% (p < 0.0001), while the number of 
true negative (TN) results decreased: from 81.9% to 
71.2% (p < 0.0001). As a result, the sensitivity of FNAB 
increased from 63.9% to 81.8% as well as PPV: from 
28.6% to 46.4% (p < 0.05 in both cases). Differences 
Table II. Comparison of histopathological results with the FNAB outcomes in the period before and after the introduction of the 
new classification of thyroid biopsy 
Tabela II. Zestawienie badań histopatologicznych z wynikami FNAB tarczycy w okresie przed i po wprowadzeniu nowej 
klasyfikacji wyników biopsji
FNAB results Histopathological results Total
Benign lesion Malignant neoplasms
oldC newC oldC newC oldC newC
ND 79 96.3% 
2.7%
9 90.0% 
2.8%
3 3.7% 
1.4%
1 10.0% 
1.8%
82 100% 
2.6%
10 100% 
2.6%
BL 2457 97.2% 
83.1%
211 96.8% 
64.7% a
71 2.8% 
32.4%
7 3.2% 
12.5% b
2,528 100% 
79.6%
218 100% 
57.1% a
FL  (–) 76 91.6% 
2.6%
54 94.7% 
16.6% a
7 8.4% 
3.2%
3 5.3% 
5.4%
83 100% 
2.6%
57 100% 
14.9% a
 (+) 261 80.9% 
8.8%
40 94.1% 
12.3% d
26 9.1% 
11.9%
3 5.9% 
5.4%
287 100% 
9.0%
43 100% 
11.3%
SM 81 81.0% 
2.7%
10 66.7% 
3.1%
19 19.0% 
8.7%
5 33.3% 
8.9%
100 100% 
3.1%
15 100% 
3.9%
MN 2 2.1% 
0.07%
2 5.1% 
0.6% c
93 97.9% 
42.5%
37 94.9% 
66.1% b
95 100% 
2.9%
39 100% 
10.2% a
Total 2,955 93.1% 
100%
326 85.6% 
100%
219 6.9% 
100%
56 14.4% a 
100%
3,175 100% 
100%
382 100% 
100%
ND — non-diagnostic results; BL — benign lesions; FL — follicular lesions; SM — suspicion for malignancy; MN —malignant neoplasms; (–) — FL ‘negative’; (+) — 
FL ‘positive’ in respect to revealing malignancy; oldC — previous classification of thyroid biopsy results; newC — new classification of thyroid biopsy results; a — p < 
0.0001 vs. oldC; b — p < 0.005 vs. oldC; c — p < 0.01 vs. oldC; d — p < 0.05 vs. oldC
Table III. The values of the parameters describing FNAB effectiveness in respect to revealing malignancy before and after the 
introduction of the new classification of thyroid biopsy 
Tabela III. Wartości parametrów opisujących skuteczność diagnostyczną FNAB przed i po wprowadzeniu nowej klasyfikacji 
wyników
Parameter FNAB outcomes
All FNAB FL only FL excluded
oldC newC oldC newC oldC newC
TP 138–4.5% 45–12.1%a 26–7.0% 3–3.0% 112–4.1% 42–15.4%a
TN 2,533–81.9% 265–71.2%a 76–20.5% 54–54.0%a 2,457–90.2% 211–77.6%a
FP 344–11.1% 52–14.0% 261–70.5% 40–40.0%a 83–3.1% 12–4.4%
FN 78–2.5% 10–2.7% 7–1.9% 3–3.0% 71–2.6% 7–2.6%
Total 3093 372 370 100 2723 272
Sensitivity 63.9% 81.8% 78.8% 50.0% 61.2% 85.7%
Specificity 88.0% 83.6% 22.6% 57.4% 96.7% 94.6%
Accuracy 86.4% 83.3% 27.6% 57.0% 94.3% 93.0%
PPV 28.6% 46.4% 9.1% 6.9% 57.4% 77.8%
NPV 97.0% 96.4% 91.6% 94.7% 97.2% 96.8%
TP — true positive; TN — true negative; FP — false positive; FN — false negative; PPV — positive predictive value; NPV — negative predictive value; oldC — previous 
classification of thyroid biopsy results; newC — new classification of thyroid biopsy results; a — p < 0.0001 vs. oldC
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in specificity were smaller (88.0% in the first period 
and 83.6% in the second one). NPV exceeded 95% in 
both periods. The area under ROC curve in the case of 
newC of FNAB results applied for dichotomic division 
of the results into benign and malignant was higher 
than in the case of the oldC: 0.902 (SE: 0.030; Cl 95%: 
0.842–0.961) vs. 0.790 (SE: 0.022; Cl 95%: 0.746–0.833).
When the analysis was limited to FL only, it was 
found that after the newC was introduced, the number 
of false positive (FP) results was significantly lower 
(70.5% vs. 40.0%, p < 0.0001), while the number of TN 
results significantly increased (20.5% vs. 54.0%, p < 
0.0001). The sensitivity of the test decreased (78.8% to 
50.0%) as well as the PPV (from 9.1% to 6.9%), while 
the specificity and accuracy increased (from 22.6% to 
57.4% and from 27.6% to 57.0%, respectively). NPV 
remained in this variant higher than 90% for both 
classifications. If the analysis comprised all the lesions 
except for FL, the number of TP results increased (4.1% 
vs. 15.4%, p < 0.0001), while the number of TN results 
decreased (90.2% vs. 77.6%, p < 0.0001). Consequently, 
the sensitivity of FNAB rose (from 61.2% to 85.7%) as 
well as PPV (from 57.4 % to 77.8%), the values of speci-
ficity, accuracy and NPV were similar: 95–97% for both 
analysed periods. 
Discussion
Limitations of basic methods used in differentiation 
of pathological lesions of the thyroid gland — US and 
FNAB — make clinicians often interpret ambiguous 
results. 
Thus, the introduction of the newC of thyroid biopsy 
was adopted readily, because it allows the identification 
of cases of a potentially lower risk of malignancy from 
the group of FL. However, the clinical significance of the 
newC has not yet been clearly formulated. Previously, 
we demonstrated that separation of FLUS subcategory 
noticeably reduced the percentage of FNAB outcomes 
of follicular nodules without the diagnostic conclusion 
[5]. It also lowered the incidence of FL regarded as posi-
tive with regard to revealing cancer. Such observations 
were also confirmed by other authors [6]. Our present 
analysis indicates that apparently the introduction of 
the newC only to a small extent influenced the distribu-
tion of the results among main cytological diagnostic 
categories. Benign lesions before, as well as after, apply-
ing the newC represented 90–91% of all diagnostic re-
sults, FL — 7–8%, SM and MN included approximately 
2% of the FNAB results. But more thorough analysis 
shows that distinguishing FLUS class had an impact 
not only on FL category, but also on the ratio of SM 
and MN results. In consequence, it led to changes in 
the values of parameters describing the effectiveness 
of FNAB. With regard to malignancy and suspicion for 
malignancy, significant changes in the ratio of these two 
categories were found — the detection of MN increased 
by 33%, whereas SM were formulated three times less 
often. This shift could be produced by two causes. One 
is a better detection of thyroid cancer in recent years 
compared to the beginning of the 2000s, due to better 
use of ultrasound malignancy risk factors for selection 
of small lesions for FNAB [7]. The second cause is the 
change in classification of smears with scant cellularity 
and single features of cancer. Now such smears can be 
classified as FLUS and not SM. In consequence of the 
discussed changes, the number of TP results increased 
as well as their PPV, and in the case of FL the number 
of TN increased and FP decreased.
A high incidence of the benign category, in both 
examined periods, probably results from the epidemio-
logical situation of the population, especially in older 
age groups. Another reason is probably a trend for 
annual monitoring of thyroid nodules with repeated 
FNAB, regardless of their potential ultrasound progress 
or previous benign cytology. On the other hand, fewer 
and fewer people with benign cytology are referred to 
surgical treatment (because of substantial enlargement 
of the thyroid). Accordingly, in the group of operated 
patients in the second period there was a significant 
increase in the percentage of patients with a positive 
FNAB result. It was also observed that the cytological 
category MN was about one third more frequent in 
patients with histopatologically confirmed malignant 
neoplasms for the last three years compared to the 
previous period, while the proportion of benign lesions 
decreased. As a result, the total sensitivity of FNAB 
significantly increased in the second period, despite 
its lowering for follicular lesions. According to our 
observations, the sensitivity and specificity of thyroid 
biopsy as well as PPV are significantly different for FL 
and other diagnostic categories. The specificity of FNAB 
with regard to lesions other than FL is about 95%. In the 
case of FL, it is significantly lower, but the introduction 
of the newC of the biopsy results led to a more than 
two-fold increase in the value of this parameter. 
We noted a slight decrease in the total incidence of 
formulating FL cytology outcomes after the introduc-
tion of the newC system. This is, in our opinion, mainly 
due to the increase in iodine supply during the analysed 
period. As shown in our previous research on a detailed 
assessment of FL category, in the case of analysing these 
changes only in the years immediately preceding the 
introduction of the new classification and a similar pe-
riod after its application (2009–2012), no significant dif-
ference in the total incidence of formulating FL results 
was found [5]. This issue undoubtedly requires further 
observation. The iodine prophylaxis has brought about 
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beneficial effects which are observed in young people, 
who are not, unlike the older generation, affected by 
non-neoplastic enlargement of the thyroid. The mean 
age of patients referred to our clinic is above 50. 
The reports of other authors on the impact of the 
new FNAB classification system on the frequency of 
formulating each type of diagnostic categories are not 
very consistent. Crowe et al. observed that the applica-
tion of the newC reduces the incidence of ambiguous 
diagnoses and frequency of surgical interventions, 
particularly with regard to benign lesions, but it does 
not affect the accuracy of cytology and the percentage 
of false positive outcomes [8]. In turn, Rabaglia et al. 
showed no impact of the introduction of the newC sys-
tem on the number of surgeries performed, but noted 
the reduced risk of malignancy in respect to ambiguous 
results of FNAB (corresponding to the FLUS category 
in the newC system) [9].
Broome and Solorzano compared the frequency 
of formulating individual diagnostic categories in the 
two periods: before and after the introduction of the 
newC, including only operated patients, and found 
a significant decrease in the frequency of formulating 
benign and malignant lesions, whereas the observed 
frequency of FLUS was higher than it had been assumed 
by the NCI [10].
As shown above, the clinical significance of the 
newC of the FNAB results has not been established 
yet. It seems that its effect on improving the reproduc-
ibility of the results is as important as its influence on 
the accuracy of the cytology examination in respect to 
revealing malignancy. This has also been confirmed 
by the analysis carried out in a retrospective system, 
through the re-evaluation of previously acquired mi-
croscopic slides. 
On the basis of such research, Richmond et al. found 
that the newC would probably help avoid certain 
surgeries of benign lesions, but it would not affect the 
accuracy of FNAB in revealing malignancy [11]. Song 
et al. observed that the application of the newC system 
reduces the number of ambiguous FNAB outcomes [12]. 
Jo et al. pointed out the advantages of improving the 
reproducibility of the cytology outcomes [13].
The newC system is still being modified in order to 
improve the accuracy of FNAB. These modifications 
include introducing another division (for example the 
further sub-division of FLUS) or merging two groups 
(like SFN and SM) [14, 15]. It seems, however, that 
these steps mainly modify the values of the parameters 
describing the effectiveness of FNAB, but are of less 
importance when interpreting a single outcome. The 
mentioned parameters are also markedly influenced 
by the epidemiological factors described above and 
the fact that the benign character of the majority of le-
sions (especially in areas rich in iodine) is never verified 
histologically [16].
Conclusions
In conclusion, the introduction of the newC of thyroid 
FNAB results caused slight changes in the distribution 
of the results among major diagnostic categories. How-
ever, the aforementioned changes have significantly 
affected the values of the parameters describing the 
effectiveness of cytology in respect to revealing ma-
lignancy. Those parameters were also markedly influ-
enced by a simultaneous improvement in selection of 
the lesions for biopsy with the use of ultrasonographic 
malignancy risk features, which allowed more thyroid 
microcancers to be revealed. It should be remembered 
that parameters describing the efficiency of FNAB are 
influenced not only by factors specific for any given 
clinic such as the rules for selection of lesions for bi-
opsy, adequacy of cytological material, reliability of 
microscopic analysis and classification of its results, 
but also by the inclusion or omission of microcancers 
incidentally found in postoperative histopathological 
examination during statistical analysis. There are also 
independent factors that include the epidemiology 
of thyroid diseases in the examined population, and 
most importantly the incidence of follicular lesions for 
which the efficiency of FNAB is markedly lower than 
for other lesions. 
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